Community Investing Ideas

Global Weekly Picks

US$18.17
FV
55.2% overvalued intrinsic discount
1.28%
Revenue growth p.a.
72
users have viewed this narrative
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$408.64
FV
36.9% undervalued intrinsic discount
20.00%
Revenue growth p.a.
107
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
₹135.87
169.7% overvalued intrinsic discount
Salman2415's Fair Value
Revenue
23% p.a.
Profit Margin
5%
Future PE
28x
Price in 2031
₹239.45
TLX logo
Telix Pharmaceuticals

TLX... a Market's Overreaction or a Falling Knife?

So just for context to any investors happening upon this narrative... What does Telix actually do?Read more

View narrative
0
users have viewed this narrative
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AU$18
45.2% undervalued intrinsic discount
Vallix's Fair Value
Profit Margin
13%
Future PE
27.9x
Price in 2029
AU$22.19
US$18.17
55.2% overvalued intrinsic discount
SteveGruber's Fair Value
Revenue
1.28% p.a.
Profit Margin
1.95%
Future PE
96.09x
Price in 2031
US$29.66